Your trusted partner in clinical research and compliance
ABOUT US
Feyti Medical Group, a Ugandan-American company, is revolutionizing the landscape of drug safety and pharmacovigilance with the transformative power of artificial intelligence (AI). Since its inception, Feyti has embarked on an unwavering pursuit of innovation, harnessing AI to enhance clinical research, streamline compliance, and usher in a new era of ethical and efficient drug development.
Our Vision
To become the world's leading AI-powered CRO, shaping the future of healthcare through groundbreaking innovation.
Our Mission
To revolutionize clinical research and compliance with AI, ushering in a new era of efficient and ethical drug development.
Our Market
Our Journey with AI: A Trailblazing Path
From the outset, Feyti Medical Group has embraced AI as a cornerstone of its success. Our team of highly skilled AI engineers and clinical experts has been at the forefront of developing AI-powered solutions that address the most pressing challenges in drug safety and pharmacovigilance. Our unwavering commitment to AI has led to the creation of cutting-edge AI-driven platforms that streamline clinical trial data management, enhance adverse event reporting, and optimize risk assessment processes.
Our Milestones: A Testament to Growth and Innovation
- 2017: Emerged as National Champions at the MTN App Challenge: Feyti Medical Group's innovative spirit and potential were recognized when it emerged victorious at the MTN App Challenge, showcasing its ability to tackle complex healthcare challenges using technology.
- 2020: Expansion into Pharmacovigilance and Regulatory Affairs Compliance and Management: Demonstrating its commitment to providing comprehensive drug safety solutions, Feyti Medical Group expanded its expertise into Pharmacovigilance and Regulatory Affairs Compliance and Management, ensuring that clients receive the highest level of support throughout the drug development process.
- 2022: Investment in AI and Automation Research for Clinical and Regulatory Compliance Management: Recognizing the transformative potential of AI in drug safety and pharmacovigilance, Feyti Medical Group made a strategic investment in AI and automation research for Clinical and Regulatory Compliance Management, laying the foundation for future groundbreaking innovations.
- 2023: Transformation into a Fully Managed CRO Serving Clients Across Three Continents – Americas, Africa, and Asia: Solidifying its global reach and impact, Feyti Medical Group transformed into a fully managed CRO, expanding its services to clients across three major continents – Americas, Africa, and Asia, demonstrating its commitment to making a global impact in drug safety.
Our Impact: A Ripple Effect of Innovation
- Empowering Pharmaceutical Companies with AI-Driven Efficiency: Feyti Medical Group's AI-powered platforms are empowering pharmaceutical companies to conduct clinical trials with greater efficiency and precision, leading to faster and more informed drug development decisions.
- Enhancing Adverse Event Reporting with AI-Powered Systems: Feyti Medical Group's AI-powered adverse event reporting systems are enabling healthcare providers to identify and address potential safety concerns with greater speed and accuracy, improving patient safety outcomes.
Our Commitment to the Future: AI-Driven Patient Care
As we move forward, Feyti Medical Group remains steadfast in its commitment to harnessing AI for the betterment of patient care. We are continually exploring new avenues of AI integration, seeking to develop groundbreaking solutions that further enhance drug safety, streamline clinical trials, and ultimately improve the lives of patients worldwide.
We are confident that AI will revolutionize drug safety and pharmacovigilance, making it possible to bring safer and more effective treatments to patients faster than ever before. Feyti Medical Group is committed to being at the forefront of this revolution, using AI to make a positive impact on the lives of millions.